Table 2.
Demographics for full cohort.
| Cohort | N | Female (%) | Average disease duration (year) | Average NeurExa | Average EDSSa |
|---|---|---|---|---|---|
| HEALTHY VOLUNTEERS | |||||
| 18–29 | 5 | 60.0 | − | − | − |
| 30–39 | 2 | 0.0 | − | − | − |
| 40–49 | 2 | 50.0 | − | 12.9 | 1.5 |
| 50–59 | 3 | 100.0 | − | 18.0 | 1.5 |
| >60 | 3 | 33.3 | − | 32.2 | 2.0 |
| MS PATIENTS | |||||
| 18–29 | 2 | 50.0 | 11.1 | 251.5 | 5.5 |
| 30–39 | 7 | 85.7 | 5.7 | 28.6 | 1.9 |
| 40–49 | 25 | 64.0 | 10.2 | 80.3 | 3.6 |
| 50–59 | 40 | 50.0 | 15.0 | 123.9 | 4.5 |
| >60 | 38 | 60.5 | 20.7 | 160.4 | 5.5 |
Patients are divided into healthy and MS cohorts stratified by age. Average disease duration and clinical scales are calculated where applicable. Percentages do not always sum to 100 due to rounding error. NeurEx (10) is obtained from an app-based documentation of the neurological exam. EDSS (1) denotes Expanded Disability Status Scale.
a
Descriptive statistics were calculated by excluding missing data.